AI Medical Compendium Journal:
Therapeutics and clinical risk management

Showing 1 to 3 of 3 articles

Adoption of Digital Therapeutics in Europe.

Therapeutics and clinical risk management
Digital therapeutics (DTx) are an emerging medical therapy comprising evidence-based interventions that are regulatory approved for patient use, or are under development, for a variety of medical conditions, including hypertension, cancer, substance ...

Predicting Bleeding Related Events in Robotic-Assisted Partial Nephrectomy for Angiomyolipoma: Simplifying Risk Assessment with Tumor Diameter and Depth, A Retrospective Study.

Therapeutics and clinical risk management
BACKGROUND: Evaluating risk factors for bleeding events in robot-assisted partial nephrectomy (RAPN) for renal angiomyolipoma (RAML) is essential for improving surgical outcomes.

Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9.

Therapeutics and clinical risk management
BACKGROUND: A beneficial effect on cardiovascular risk may be obtained by improving lipid-related serum lipoprotein functions such as high-density lipoproteins (HDLs) cholesterol efflux capacity (CEC) and serum cholesterol loading capacity (CLC) and ...